Cancer Family
Leukemia
CI-CAN-00000215Explore in graph →
HematologicTop-level1,769 active trials42 approved drugs708 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000215Explore in graph →
Clinical trials
8,437 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,348)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00086580 | Fludarabine (Fludara®) Plus Alemtuzumab (CAMPATH®, MabCampath®) vs Fludarabine Alone in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients | completed | Phase 3 | 335 | Genzyme, a Sanofi CompanyINDUSTRY | 15 | Mar 13, 2014 | clinicaltrials |
| NCT00438958 | Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseases | completed | Phase 3 | 230 | The Canadian Blood and Marrow Transplant GroupNETWORK | 5 |
| Mar 5, 2014 |
| clinicaltrials |
| NCT02072785 | Phase III Study of Vincristine Sulfate Liposome For Injection In Adults With Naïve Acute Lymphoblastic Leukemia(LY01609) | unknown | Phase 3 | 480 | Nanjing Luye Sike Pharmaceutical Co., Ltd.INDUSTRY | 1 | Mar 3, 2014 | clinicaltrials |
| NCT00022737 | Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Children With Acute Lymphoblastic Leukemia | completed | Phase 3 | 220 | National Cancer Institute (NCI)NIH | 1 | Feb 27, 2014 | clinicaltrials |
| NCT02072811 | Role of the Therapy Tailored to Risk Factors in Treating Adult Patients (≤60) With Acute Myeloid Leukemia(PALG-AML2012) | unknown | Phase 3 | 400 | dr hab. n. med. Agnieszka WierzbowskaOTHER | 1 | Feb 27, 2014 | clinicaltrials |
| NCT00005603 | Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia | completed | Phase 3 | 276 | Children's Oncology GroupNETWORK | 1 | Feb 20, 2014 | clinicaltrials |
| NCT00015873 | Comparison of Different Combination Chemotherapy Regimens in Treating Infants With Acute Lymphoblastic Leukemia | completed | Phase 3 | 350 | Dutch Childhood Oncology GroupOTHER | 11 | Feb 17, 2014 | clinicaltrials |
| NCT01400074 | Efficacy of Nilotinib Versus Imatinib in Ph+ CML in Early CP Who Have a Suboptimal Molecular Response to Imatinib(RE-NICE) | unknown | Phase 3 | 100 | Seoul St. Mary's HospitalOTHER | 1 | Jan 13, 2014 | clinicaltrials |
| NCT00482716 | Epoetin Alfa or Epoetin Beta With or Without Iron Infusion in Treating Anemia in Patients With Cancer | unknown | Phase 3 | 80 | St. Bartholomew's HospitalOTHER | 1 | Jan 10, 2014 | clinicaltrials |
| NCT01819389 | Low-dose Nilotinib and Imatinib Combination in Chronic Myeloid Leukemia Patients, With Failure, Suboptimal Response or Treatment Intolerance | completed | Phase 3 | 10 | Hospital Universitario Dr. Jose E. GonzalezOTHER | 1 | Jan 7, 2014 | clinicaltrials |
| NCT00024440 | Fludarabine and Cyclophosphamide With or Without Oblimersen in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia | completed | Phase 3 | — | Genta IncorporatedINDUSTRY | 1 | Jan 6, 2014 | clinicaltrials |
| NCT00454168 | Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia in Remission | unknown | Phase 3 | 244 | The Vaccine CompanyINDUSTRY | 1 | Jan 6, 2014 | clinicaltrials |
| NCT00428558 | Timed-Sequential Induction in CBF-AML | completed | Phase 3 | 200 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Dec 20, 2013 | clinicaltrials |
| NCT00002658 | Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia | unknown | Phase 3 | 2,000 | Medical Research CouncilOTHER_GOV | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00002869 | Interferon Alfa in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia | unknown | Phase 3 | 800 | Medical Research CouncilOTHER_GOV | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00005863 | Combination Chemotherapy With or Without Filgrastim and/or Tretinoin in Treating Patients With Acute Myeloid Leukemia | completed | Phase 3 | — | Medical Research CouncilOTHER_GOV | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00020865 | Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia | unknown | Phase 3 | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00004218 | Chemotherapy in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia | completed | Phase 3 | — | Leukemia Research FundOTHER | 8 | Dec 18, 2013 | clinicaltrials |
| NCT00005823 | Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome | completed | Phase 3 | 2,000 | Leukemia Research FundOTHER | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00025402 | Chemotherapy and Biological Therapy With or Without Bone Marrow or Peripheral Stem Cell Transplant in Treating Patients With Chronic Myelogenous Leukemia | unknown | Phase 3 | 1,000 | III. Medizinische Klinik MannheimOTHER | 5 | Dec 18, 2013 | clinicaltrials |
| NCT00003436 | Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myeloid Leukemia | completed | Phase 3 | 2,000 | Medical Research CouncilOTHER_GOV | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00003437 | Hormone Therapy Plus Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia | unknown | Phase 3 | 1,800 | Medical Research CouncilOTHER_GOV | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00968838 | A Study for Leukemia Patients With Life-Threatening Infections | completed | Phase 3 | 178 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 26, 2013 | clinicaltrials |
| NCT01110824 | Prevention of Left Ventricular Dysfunction During Chemotherapy(OVERCOME) | completed | Phase 3 | 90 | Hospital Clinic of BarcelonaOTHER | 1 | Nov 15, 2013 | clinicaltrials |
| NCT00003991 | Interleukin-2 Plus Histamine Dihydrochloride in Treating Patients With Acute Myeloid Leukemia | completed | Phase 3 | 360 | Maxim PharmaceuticalsINDUSTRY | 12 | Nov 6, 2013 | clinicaltrials |
| NCT00006045 | Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia | unknown | Phase 3 | — | Facet BiotechINDUSTRY | 7 | Nov 6, 2013 | clinicaltrials |
| NCT00112554 | Cytarabine With or Without VNP40101M in Treating Patients With Relapsed Acute Myeloid Leukemia | completed | Phase 3 | 420 | Vion PharmaceuticalsINDUSTRY | 10 | Nov 6, 2013 | clinicaltrials |
| NCT00002961 | Chemotherapy With or Without Total-Body Irradiation Prior to Bone Marrow Transplantation in Treating Children With Acute Lymphoblastic Leukemia | terminated | Phase 3 | 43 | Children's Hospital of PhiladelphiaOTHER | 2 | Oct 16, 2013 | clinicaltrials |
| NCT00333840 | Safety and Efficacy of Imatinib Versus Interferon-α Plus Cytarabine in Patients With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia | completed | Phase 3 | 1,106 | Novartis PharmaceuticalsINDUSTRY | 16 | Oct 14, 2013 | clinicaltrials |
| NCT01147939 | Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)(CLAVELA) | completed | Phase 3 | 381 | Clavis PharmaINDUSTRY | 13 | Sep 27, 2013 | clinicaltrials |
| NCT00002499 | Combination Chemotherapy in Treating Children With Relapsed Acute Lymphocytic Leukemia | unknown | Phase 2 / Phase 3 | — | Grupo Argentino de Tratamiento de la Leucemia AgudaOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00002701 | Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Promyelocytic Leukemia | unknown | Phase 3 | 750 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Sep 20, 2013 | clinicaltrials |
| NCT00003602 | Combination Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia | unknown | Phase 3 | 400 | Riverside Haematology GroupOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00281918 | Fludarabine and Cyclophosphamide With or Without Rituximab in Patients With Previously Untreated Chronic B-Cell Lymphocytic Leukemia(CLL-8) | completed | Phase 3 | 817 | Hoffmann-La RocheINDUSTRY | 11 | Sep 19, 2013 | clinicaltrials |
| NCT00047268 | Donor Stem Cell Transplant With or Without Chemotherapy in Treating Children With Primary Myelodysplastic Syndrome | unknown | Phase 3 | — | European Working Group of MDS in ChildhoodOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT00943709 | Intensive Glycemic Control on Infectious Morbidity In Patients With Acute Leukemia | withdrawn | Phase 3 | 0 | University of Medicine and Dentistry of New JerseyOTHER | 1 | Aug 30, 2013 | clinicaltrials |
| NCT00002812 | Combination Chemotherapy in Treating Children With Acute Lymphocytic Leukemia | completed | Phase 3 | 2,078 | Children's Oncology GroupNETWORK | 3 | Aug 26, 2013 | clinicaltrials |
| NCT00454480 | Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes | completed | Phase 2 / Phase 3 | 2,000 | The University of New South WalesOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00002816 | Combination Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia | completed | Phase 3 | 120 | Children's Oncology GroupNETWORK | 3 | Aug 22, 2013 | clinicaltrials |
| NCT00005977 | Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia | completed | Phase 3 | 83 | Children's Oncology GroupNETWORK | 6 | Aug 21, 2013 | clinicaltrials |
| NCT00967057 | Combination Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia | completed | Phase 3 | 470 | Children's Cancer and Leukaemia GroupOTHER | 2 | Aug 12, 2013 | clinicaltrials |
| NCT00002771 | Chemotherapy, Interferon, and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia | unknown | Phase 3 | 750 | German CML Study GroupOTHER | 1 | Aug 2, 2013 | clinicaltrials |
| NCT00564512 | Fludarabine, Cyclophosphamide, and Rituximab or Alemtuzumab in Treating CLL2007 CLL 2007 FMP | completed | Phase 3 | 178 | French Innovative Leukemia OrganisationOTHER | 1 | Jul 25, 2013 | clinicaltrials |
| NCT00927498 | A Randomized Study of Gemtuzumab Ozogamicin (GO) With Daunorubicine and Cytarabine in Untreated Acute Myeloid Leukemia (AML) Aged of 50-70 Years Old | completed | Phase 3 | 280 | Acute Leukemia French AssociationOTHER | 1 | Jul 11, 2013 | clinicaltrials |
| NCT00004255 | Treatment of Bone Marrow to Prevent Graft-Versus-Host Disease in Patients With Acute or Chronic Leukemia Undergoing Bone Marrow Transplantation | completed | Phase 2 / Phase 3 | — | Chimeric TherapiesINDUSTRY | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00003341 | Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By Chemotherapy | completed | Phase 3 | 275 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 3, 2013 | clinicaltrials |
| NCT00003593 | Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome | completed | Phase 3 | 254 | Children's Oncology GroupNETWORK | 7 | Jun 27, 2013 | clinicaltrials |
| NCT00002534 | Bone Marrow Transplantation in Treating Patients With Acute Leukemia in First or Second Remission | completed | Phase 3 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00006223 | flt3L in Treating Patients With Acute Myeloid Leukemia | completed | Phase 3 | — | Eastern Cooperative Oncology GroupNETWORK | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00150878 | Standard vs. Reduced-Intensity Conditioning in Patients With Acute Myeloid Leukemia in First Remission | terminated | Phase 3 | 198 | University Hospital Carl Gustav CarusOTHER | 1 | Jun 20, 2013 | clinicaltrials |
Data updated 22 days agoSource updated Mar 13, 2014source: clinicaltrials